Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Moreau

Showing results (111-120 of 160) with videos related to

Pageof 16
Sort By:
Annals of Hematology|May 18, 2020
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real lifeClara Sortais, Anne Lok, Benoit Tessoulin, et al.
Haematologica|September 29, 2018
Highly sensitive methods are required to detect mutations in histiocytosesSarah Melloul, Zofia Hélias-Rodzewicz, Fleur Cohen-Aubart, et al.
The American Journal of Surgical Pathology|March 20, 2009
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomasYenlin Huang, Anne Moreau, Jehan Dupuis, et al.
Kidney International Reports|March 18, 2021
Spectrum of Kidney Involvement in Patients with Myelodysplastic SyndromesNora Schwotzer, François Provot, Simon Ville, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2010
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupCaroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, et al.
Developmental Cell|September 23, 2020
A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart DevelopmentJennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2007
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceSophie Brouard, Elaine Mansfield, Christophe Braud, et al.
Transplantation|July 17, 2012
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?Pierre Peterlin, Christophe Leux, Thomas Gastinne, et al.
Kidney International|February 26, 2010
Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejectionJoanna Ashton-Chess, Hoa Le Mai, Vojislav Jovanovic, et al.
British Journal of Haematology|December 15, 2005
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des MyélodysplasiesDidier Bouscary, Laurence Legros, Micheline Tulliez, et al.
Pageof 16

Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Annals of Hematology|May 18, 2020
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real lifeClara Sortais, Anne Lok, Benoit Tessoulin, et al.
Haematologica|September 29, 2018
Highly sensitive methods are required to detect mutations in histiocytosesSarah Melloul, Zofia Hélias-Rodzewicz, Fleur Cohen-Aubart, et al.
The American Journal of Surgical Pathology|March 20, 2009
Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomasYenlin Huang, Anne Moreau, Jehan Dupuis, et al.
Kidney International Reports|March 18, 2021
Spectrum of Kidney Involvement in Patients with Myelodysplastic SyndromesNora Schwotzer, François Provot, Simon Ville, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2010
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupCaroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, et al.
Developmental Cell|September 23, 2020
A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart DevelopmentJennifer H Kong, Cullen B Young, Ganesh V Pusapati, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2007
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceSophie Brouard, Elaine Mansfield, Christophe Braud, et al.
Transplantation|July 17, 2012
Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?Pierre Peterlin, Christophe Leux, Thomas Gastinne, et al.
Kidney International|February 26, 2010
Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejectionJoanna Ashton-Chess, Hoa Le Mai, Vojislav Jovanovic, et al.
British Journal of Haematology|December 15, 2005
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des MyélodysplasiesDidier Bouscary, Laurence Legros, Micheline Tulliez, et al.
Pageof 16